The role of the viral vector in today’s gene therapy advancements.
Scientists in the field of gene therapy can deliver a functioning gene into the retina of the human eye, using viruses as the transporter of that gene. The viral vector is the microscopic powerhouse in these efforts—and something you will want to know about!
We are constantly connecting with folks in the IRD community to bring new stories to aSharedVision. Check out the latest additions.
Did you know there are as many as 7,000 rare diseases impacting the lives of ~25–30 million Americans, many of them children? To commemorate Rare Disease Day 2018 and raise awareness of these diseases, we encourage patients to share their stories, build communities, and help advance research for change. Read more
Happy New Year! Before we get too far into 2018, let's look back at 2017 on aSharedVision. We crunched a few numbers to discover: 1) who makes up our community, 2) which stories they are most interested in, and, 3) which inherited retinal diseases (IRDs) they wanted to learn more about. Read on!
We reached out to a University of California, San Francisco clinician and researcher to get her take on the quickly evolving research landscape and the growing mandate for genetic testing. Read more